"UPMC Hillman Cancer Center at Arnold Palmer Pavilion, in partnership with Excela Health is a cancer treatment center located in North Huntingdon, Pa. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center Arnold Palmer at Norwin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center Arnold Palmer at Norwin" #1 collaborator was "MacroGenics" with 1 trials as a collaborator and "Translational Breast Cancer Research Consortium" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center Arnold Palmer at Norwin" are "Breast Cancer" (1 trials), "HER2-positive Breast Cancer" (1 trials), "Primary Invasive Breast Cancer" (1 trials), "Stage II Breast Cancer" (1 trials) and "Stage III Breast Cancer" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center Arnold Palmer at Norwin" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center Arnold Palmer at Norwin" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Margetuximab" (1 trials), "Observational" (1 trials), "Paclitaxel" (1 trials), "Pertuzumab" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center Arnold Palmer at Norwin" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center Arnold Palmer at Norwin". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UPMC Hillman Cancer Center Arnold Palmer at Norwin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center Arnold Palmer at Norwin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".